AXON:NYE-Axovant Sciences Ltd. (USD)

EQUITY | Aerospace & Defense | New York Stock Exchange

Last Closing

USD 731.37

Change

0.00 (0.00)%

Market Cap

USD 1.28B

Volume

0.42M

Analyst Target

USD 4.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Axovant Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Aerospace & Defense

Symbol Name Price(Change) Market Cap
ESLT Elbit Systems Ltd

+6.48 (+1.71%)

USD 18.73B
RKLB Rocket Lab USA Inc.

+3.34 (+13.14%)

USD 11.73B
WWD Woodward Inc

+7.86 (+3.73%)

USD 11.69B
AVAV AeroVironment Inc

+9.07 (+5.36%)

USD 7.55B
KTOS Kratos Defense & Security Solu..

+2.11 (+5.86%)

USD 5.15B
MRCY Mercury Systems Inc

+1.90 (+4.03%)

USD 2.77B
VSEC VSE Corporation

+3.28 (+2.59%)

USD 2.36B
EH Ehang Holdings Ltd

-1.18 (-6.96%)

USD 1.21B
ATRO Astronics Corporation

+1.53 (+5.07%)

USD 0.74B
BYRN Byrna Technologies Inc

+1.84 (+7.71%)

USD 0.49B

ETFs Containing AXON

GUNZ Tuttle Capital Self Defen.. 5.52 % 0.00 %

-0.19 (-0.65%)

USD 0.55M
XAR SPDR® S&P Aerospace & De.. 4.44 % 0.35 %

+6.49 (+-0.65%)

USD 3.07B
XAD:CA iShares U.S. Aerospace & .. 4.42 % 0.00 %

+1.51 (+-0.65%)

N/A
PPA Invesco Aerospace & Defen.. 4.03 % 0.59 %

+3.00 (+-0.65%)

USD 5.12B
SAGP The Advisorsa Inner Circl.. 2.53 % 0.00 %

+0.22 (+-0.65%)

USD 0.05B
IWP iShares Russell Mid-Cap G.. 1.69 % 0.24 %

+2.42 (+-0.65%)

USD 18.06B
EQQJ:LSE Invesco NASDAQ Next Gener.. 1.55 % 0.00 %

+0.72 (+-0.65%)

N/A
QWST 1.36 % 0.00 %

N/A

N/A
IQCY:LSE Amundi Index Solutions - .. 1.25 % 0.00 %

+0.99 (+-0.65%)

N/A
QQQE Direxion NASDAQ-100 Equal.. 1.25 % 0.35 %

+1.71 (+-0.65%)

USD 1.15B
FMDE Fidelity Covington Trust 0.98 % 0.00 %

+0.62 (+-0.65%)

USD 2.61B
TRFM ETF Series Solutions - AA.. 0.98 % 0.00 %

+0.86 (+-0.65%)

USD 0.06B
JOET Virtus ETF Trust II 0.89 % 0.00 %

+0.69 (+-0.65%)

USD 0.19B
EL41:XETRA Deka MSCI USA MC UCITS ET.. 0.71 % 0.00 %

+0.22 (+-0.65%)

USD 0.04B
JPSC:XETRA JPMorgan BetaBuilders US .. 0.41 % 0.00 %

+0.34 (+-0.65%)

N/A
CHEP 0.00 % 1.12 %

N/A

N/A
ITA iShares U.S. Aerospace & .. 0.00 % 0.42 %

+4.23 (+-0.65%)

USD 3.70B
QQXT First Trust NASDAQ-100 Ex.. 0.00 % 0.60 %

+1.76 (+-0.65%)

USD 0.99B
SCHM Schwab U.S. Mid-Cap ETF 0.00 % 0.05 %

+0.55 (+-0.65%)

N/A
VB Vanguard Small-Cap Index .. 0.00 % 0.05 %

+5.23 (+-0.65%)

N/A
DFEN Direxion Daily Aerospace .. 0.00 % 1.09 %

+2.90 (+-0.65%)

USD 0.21B
BFTR 0.00 % 0.00 %

N/A

N/A
QQQN 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Aerospace & Defense) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.06% 69% C- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.06% 69% C- 88% B+
Trailing 12 Months  
Capital Gain 156.06% 88% B+ 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 156.06% 88% B+ 96% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 40.79% 79% B- 87% B+
Dividend Return 40.79% 79% B- 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 54.71% 44% F 33% F
Risk Adjusted Return 74.55% 85% B 90% A-
Market Capitalization 1.28B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Aerospace & Defense) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 175.39 14% 7%
Price/Book Ratio 22.28 11% 6%
Price / Cash Flow Ratio 139.45 7% 2%
Price/Free Cash Flow Ratio 142.37 4% 3%
Management Effectiveness  
Return on Equity 15.17% 89% 85%
Return on Invested Capital 2.04% 55% 60%
Return on Assets 0.68% 63% 61%
Debt to Equity Ratio 29.23% 30% 50%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.